ArticleFrontiers in immunology2022

Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma.

Mariam Oladejo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.